- Home
- ELDN vs NRDY Comparison
ELDN vs NRDY Comparison
Compare ELDN & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- NRDY
- Stock Information
- Founded
- ELDN 2004
- NRDY 2007
- Country
- ELDN United States
- NRDY United States
- Employees
- ELDN N/A
- NRDY N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- NRDY Computer Software: Prepackaged Software
- Sector
- ELDN Health Care
- NRDY Technology
- Exchange
- ELDN Nasdaq
- NRDY Nasdaq
- Market Cap
- ELDN 239.6M
- NRDY 220.5M
- IPO Year
- ELDN N/A
- NRDY N/A
- Fundamental
- Price
- ELDN $4.34
- NRDY $1.71
- Analyst Decision
- ELDN Strong Buy
- NRDY Hold
- Analyst Count
- ELDN 1
- NRDY 8
- Target Price
- ELDN $16.00
- NRDY $2.35
- AVG Volume (30 Days)
- ELDN 553.2K
- NRDY 3.4M
- Earning Date
- ELDN 11-12-2024
- NRDY 11-07-2024
- Dividend Yield
- ELDN N/A
- NRDY N/A
- EPS Growth
- ELDN N/A
- NRDY N/A
- EPS
- ELDN N/A
- NRDY N/A
- Revenue
- ELDN N/A
- NRDY $197,325,000.00
- Revenue This Year
- ELDN N/A
- NRDY N/A
- Revenue Next Year
- ELDN N/A
- NRDY $2.86
- P/E Ratio
- ELDN N/A
- NRDY N/A
- Revenue Growth
- ELDN N/A
- NRDY 9.55
- 52 Week Low
- ELDN $1.43
- NRDY $0.73
- 52 Week High
- ELDN $5.54
- NRDY $3.60
- Technical
- Relative Strength Index (RSI)
- ELDN 42.46
- NRDY 60.30
- Support Level
- ELDN $4.32
- NRDY $1.46
- Resistance Level
- ELDN $4.76
- NRDY $2.18
- Average True Range (ATR)
- ELDN 0.39
- NRDY 0.26
- MACD
- ELDN -0.09
- NRDY -0.01
- Stochastic Oscillator
- ELDN 2.65
- NRDY 39.87
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.